Metallo- -lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
Open Access
- 12 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (3) , 474-478
Abstract
To study the prevalence, nature, involved genetic elements and epidemiology of metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and Pseudomonas putida isolated in a Spanish hospital between 2005 and 2008. Etests were used for susceptibility testing and screening for MBLs, confirmed through blaVIM PCRs and sequencing. Clonal relatedness was evaluated by PFGE and multilocus sequence typing (MLST). MBL-carrying plasmids were characterized by restriction fragment length polymorphism, Southern blot and electroporation. MBL genetic elements were studied by cloning and sequencing. MBL-producing P. putida was detected in eight patients (one clone each; two harbouring blaVIM-1 and six harbouring blaVIM-2), representing 14% of all the infections by the P. putida/fluorescens group. MBLs were detected in only 0.3% of P. aeruginosa infections (11 patients) during the same period. PFGE revealed four P. aeruginosa clones: one producing blaVIM-13 (two patients); and three producing blaVIM-2 (two patients, six patients and one patient, respectively). MLST indicated that the VIM-13 clone was the internationally spread sequence type (ST)235, while the major VIM-2 lineage corresponded to ST179, which is associated with chronic respiratory infections. The VIM-1 integron was shown to have both plasmid and chromosomal location, while the VIM-13 integron was only chromosomal. The VIM-2 integron was located in the same transposon (Tn402/Tn5053-like) in all P. aeruginosa and P. putida isolates, suggesting its crucial role in the dissemination of VIM-2. The high diversity and proportion of MBL-positive P. putida suggests an environmental reservoir of these resistance determinants. Dissemination of these multidrug resistance elements to successful P. aeruginosa clones presents a major epidemiological and clinical threat.Keywords
This publication has 13 references indexed in Scilit:
- Characterization of the New Metallo-β-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in SpainAntimicrobial Agents and Chemotherapy, 2008
- Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health ProblemAntimicrobial Agents and Chemotherapy, 2008
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum β-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal ComplexJournal of Clinical Microbiology, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millenniumClinical Microbiology and Infection, 2007
- Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction inPseudomonas aeruginosaClinical StrainsAntimicrobial Agents and Chemotherapy, 2005
- Development of a Multilocus Sequence Typing Scheme for the Opportunistic Pathogen Pseudomonas aeruginosaJournal of Clinical Microbiology, 2004
- From pieces to patterns: evolutionary engineering in bacterial pathogensNature Reviews Microbiology, 2004
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002